Prolonged Effect of Botulinum Toxin Injection in the Treatment of Cricopharyngeal Dysphagia: Case Report and Literature Review

Dysphagia

Volumn 19, Issue 1, 2004, Pages 52-57

  Chiu, Ming Jang ^a   Chang, Yeun Chung ^a   Hsiao, Tzu Yu ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Botulinum toxin type A; Cricopharyngeus muscle spasm; Deglutition; Deglutition disorders; Dysphagia

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; CORRELATION ANALYSIS; CRICOPHARYNGEAL DYSPHAGIA; CRICOPHARYNGEUS MUSCLE; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DYSPHAGIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE SPASM; NEUROLOGIC EXAMINATION; PHARYNX DISEASE; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXINS; DEGLUTITION DISORDERS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; LARYNGOSCOPY; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; SPASM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0842327994     PISSN: 0179051X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00455-003-0029-3     Document Type: Article

References (28)

1. Jankovic J, Brin MF: Therapeutic use of botulinum toxin. N Engl J Med 324:1186-1192, 1991
2. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN: Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 332:774-778, 1995
3. Jones MP: Botulinum toxin in hypertensive lower esophageal sphincter. Am J Gastroenterol 91:1283-1284, 1996
4. Schneider J, Thumfart W, Potoschnig C, Eckel HE: Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method. Ann Otol Rhinol Laryngol 103:31-35, 1994
5. Blitzer A, Brin MF: Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia. Otolaryngol Head Neck Surg 116:328-329, 1997
6. Blitzer A: Cricopharyngeal muscle spasm and dysphagia. Op Tech Otolaryngol Head Neck Surg 8:191-192, 1997
7. Born LJ, Harned RH, Rillers LF, Peiffer RF, Quigley EM: Cricopharyngeal dysfunction in Parkinson's disease: role in dysphagia and response to myotomy. Mov Disord 11:53-58, 1996
8. Mackenna JA, Dedo HH: Cricopharyngeal myotomy: indications and technique. Ann Otol Rhinol Laryngol 101:216-221, 1992
9. St. Guily J, Perie S, Willig T: Swallowing disorders in muscular disease: functional assessment and indication of cricopharyngeal myotomy. Ear Nose Throat J 73:34-40, 1994
10. Atkinson SI, Rees J: Botulinum toxin for circopharyngeal dysphagia: Case reports of CT guided injection. J Otolaryngol 26:273-276, 1997
11. Ahsan SF, Meleca RJ, Dworkin JP: Botulinum toxin injection of the cricopharyngeus muscle for the treatment of dysphagia. Otolaryngol Head Neck Surg 122:691-695, 2000
12. Parameswaran MS, Soliman AM: Endoscopic botulinum toxin injection for cricopharyngeal dysphagia. Ann Otol Rhinol Laryngol 111:871-874, 2002
13. Restivo DA, Plameri A, Marchese-Ragona R: Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease. N Engl J Med 346:1174-1175, 2002
14. Restivo DA, Marchese-Ragona R, Staffieri A, de Grandis D: Successful botulinum toxin treatment of dysphagia in oculopharyngeal muscular dystrophy. Gastroenterology 119:1416, 2000
15. Marion ME, Sheehy M, Sangla S, Soulayrol S: Dose standardization of botulinum toxin. Lancet 59:102-103, 1995
16. Odergren T, Hjaltasaon H, Kaakkola S, Solders G, Hanko J, Fehling C, et al.: A double blind, randomized parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry 64:6-12, 1998
17. Brandypadhyay S, Clark AW, Desgupta BR, Sathyamoorthy V: Role of the heavy and light chain of botulinum neurotoxin in neuromuscular paralysis. J Biol Chem 262:2660-2663, 1987
18. 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis. J Cell Biol 103:535-544, 1986
19. Coffield JA, Considine RV, Simpson LL: The site and mechanism of action of botulinum neurotoxin. In: Jankovic J, Hallet M (eds.): Therapy with Botulinum Toxin. New York: Marcel Dekker, 1994, pp 3-13
20. Blasi J, Chapman ER, Link E, et al.: Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365:160-163, 1993
21. Alderson K, Holds JB, Anderson RL. Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm. Neurology 41:1800-1805, 1991
22. de Paiva A, Meunier FA, Molgo J, Aoki KR, Dolly JO: Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 96:3200-3205, 1999
23. Brown P: Pathophysiology of spasticity. J Neurol Neurosurg Psychiatry 57:773-777, 1994
24. On AY, Kirazli Y, Kismali B, Aksit R: Mechanisms of action of phenol block and botulinus toxin type A in relieving spasticity: electrophysiologic investigation and follow-up. Am J Phys Med Rehabil 78:344-349, 1999
25. Duchen LW: Changes in the electron microscope structure of slow and fast skeletal muscle fibres of the mouse after local injection of botulinum toxin. J Neurol Sci 14:61-71, 1971
26. Lund WS: The function of the cricopharyngeal sphincter during swallowing. Acta Otolaryngol 59:497-510, 1964
27. Mu L, Sanders I: Muscle fiber-type distribution pattern in the human cricopharyngeus muscle. Dysphagia 17:87-96, 2002
28. D'Onofrio V, Miletto P, Leandro G, Iaguinto G: Long-term follow-up of achalasia patients treated with botulinum toxin. Dig Liver Dis 34:105-110, 2002